Amneal Pharmaceuticals Inc Class A (AMRX)

Total Costs & Expenses

$2.71B

TTM · Period ending: · USD

AMRX logo

AMRX Total Costs & Expenses

Latest reported$2.71B
AMRX TTM Total Costs & Expenses ($793.76M → $2.71B)
High-resolution chart · PNG

AMRX total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amneal Pharmaceuticals Inc Class A Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
2,714,313,000
2,677,232,000
2,692,656,000
2,647,564,000
2,476,593,000
2,469,767,000
2,544,631,000
2,492,694,000
2,423,427,000
2,336,079,000
2,189,233,000
2,160,172,000
2,116,984,000
2,355,995,000
2,307,232,000
2,259,226,000
2,258,100,000
1,968,083,000
1,940,953,000
1,905,088,000
1,921,869,000
1,907,824,000
1,901,368,000
1,831,975,000
1,743,473,000
1,706,763,000
1,771,521,000
1,786,948,000
1,760,448,000
1,686,124,000
1,385,124,000
1,164,379,000
957,698,000
830,007,000
793,763,000
801,338,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.